Aortic Insufficiency and Hemocompatibility-related Adverse Events in Patients with Left Ventricular Assist Devices: AI and HRAE.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of cardiac failure"
DOI: 10.1016/j.cardfail.2019.08.003
Abstract: AIM Hemocompatibility-related adverse events (HRAE) are a major cause of readmissions in patients with left ventricular assist device (LVAD). The impact of aortic insufficiency (AI) on HRAE remains uncertain. We aimed to investigate the impact… read more here.
Keywords: hrae; patients left; related adverse; hemocompatibility ... See more keywords
Comparison of two individualized antithrombotic protocols in heartware HVAD recipients.
Sign Up to like & getrecommendations! Published in 2021 at "Artificial organs"
DOI: 10.1111/aor.14055
Abstract: BACKGROUND We previously reported low rates of pump thrombosis and hemorrhagic stroke, but increased bleeding, under our original antithrombosis protocol (P1) in Heartware recipients. We designed and implemented a revised protocol (P2) to reduce complexity… read more here.
Keywords: incidence; use; hrae; antiplatelet ... See more keywords
Quality of Life Metrics in LVAD Patients after Hemocompatibility-Related Adverse Events.
Sign Up to like & getrecommendations! Published in 2022 at "Artificial organs"
DOI: 10.1111/aor.14235
Abstract: BACKGROUND Hemocompatibility-related adverse events (HRAE) negatively influence survival. However, no study has examined the impact of these events on health-related quality of life (HRQOL) and functional outcomes following continuous flow left ventricular assist device implantation… read more here.
Keywords: hrae; adverse events; related adverse; hemocompatibility related ... See more keywords